1. Home
  2. GOODO vs SRPT Comparison

GOODO vs SRPT Comparison

Compare GOODO & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOODO
  • SRPT
  • Stock Information
  • Founded
  • GOODO N/A
  • SRPT 1980
  • Country
  • GOODO United States
  • SRPT United States
  • Employees
  • GOODO 72
  • SRPT N/A
  • Industry
  • GOODO Real Estate
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOODO Real Estate
  • SRPT Health Care
  • Exchange
  • GOODO Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • GOODO N/A
  • SRPT 1.7B
  • IPO Year
  • GOODO N/A
  • SRPT 1997
  • Fundamental
  • Price
  • GOODO $20.23
  • SRPT $18.44
  • Analyst Decision
  • GOODO
  • SRPT Buy
  • Analyst Count
  • GOODO 0
  • SRPT 25
  • Target Price
  • GOODO N/A
  • SRPT $61.57
  • AVG Volume (30 Days)
  • GOODO N/A
  • SRPT 8.0M
  • Earning Date
  • GOODO N/A
  • SRPT 08-06-2025
  • Dividend Yield
  • GOODO N/A
  • SRPT N/A
  • EPS Growth
  • GOODO N/A
  • SRPT N/A
  • EPS
  • GOODO N/A
  • SRPT N/A
  • Revenue
  • GOODO N/A
  • SRPT $2,233,371,000.00
  • Revenue This Year
  • GOODO N/A
  • SRPT $26.87
  • Revenue Next Year
  • GOODO N/A
  • SRPT $3.15
  • P/E Ratio
  • GOODO N/A
  • SRPT N/A
  • Revenue Growth
  • GOODO N/A
  • SRPT 59.15
  • 52 Week Low
  • GOODO N/A
  • SRPT $16.88
  • 52 Week High
  • GOODO N/A
  • SRPT $154.13
  • Technical
  • Relative Strength Index (RSI)
  • GOODO 39.85
  • SRPT 33.43
  • Support Level
  • GOODO $20.13
  • SRPT $17.95
  • Resistance Level
  • GOODO $20.65
  • SRPT $19.79
  • Average True Range (ATR)
  • GOODO 0.16
  • SRPT 1.06
  • MACD
  • GOODO -0.05
  • SRPT 1.03
  • Stochastic Oscillator
  • GOODO 27.78
  • SRPT 82.99

About GOODO Gladstone Commercial Corporation 6.00% Series G Cumulative Redeemable Preferred Stock par value $0.001 per share

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: